The Greater Manchester, Lancashire and South Cumbria Medicines for Children Research Network (GMLC) is hosted at the regional paediatric tertiary centre, the Royal Manchester Children's Hospital (RMCH) in Manchester.
GMLC is led by Network Director Professor Peter Clayton, an academic in child health at The University of Manchester and Honorary Consultant Endocrinologist at the RMCH. The network is overseen by a Board who assist with strategic development and ensure GMLC fulfils its aims and objectives, including national targets.
GMLC comprises of a team of dedicated research staff who help local staff at NHS organisations to increase the number of children enrolled into MCRN adopted clinical trials and other paediatric research studies on the NIHR Clinical Research Network study portfolio. The core GMLC team are based at RMCH, but we have staff based at almost all hospitals across our region, and also fund Research Leads (insert research champion document) to champion our research at each District General Hospital.
The network aims to help in 3 key areas: